Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease

42, Lille

41, Mougins

40, Nîmes

6, Alzenau in Unterfranken

51, Aschaffenburg

13, Beelitz-Heilstätten

12, Berlin

5, Böblingen

53, Düsseldorf

7, Erbach im Odenwald

4, Haag

11, Leer

2, Münster

54, Schriesheim

8, Senftenberg

14, Tübingen

10, Ulm

3, Westerstede

45, Ancona

47, Brescia

60, Cagliari

29, Cosenza

30, Florence

46, Milan

27, Napoli

28, Roma

62, Roma

20, Barakaldo

15, Donostia / San Sebastian

24, Madrid

22, Palma de Mallorca

37, Bury

49, Cambridge

52, Lincoln

48, Liverpool

33, London

36, London

34, Manchester

31, Middlesbrough

38, North Shields

35, Norwich

63, Plymouth